Public Health Forum: Development of ARV Resistance and the Implications for HIV Treatment and Prevention Programs (International Health)

Starts:
12:30 pm on Wednesday, February 12, 2014
Ends:
1:20 pm on Wednesday, February 12, 2014
Location:
Keefer Auditorium
Development of ARV Resistance and the Implications for HIV Treatment and Prevention Programs. Dr. Tobias Rinke de Wit has been the Director Research at PharmAccess Foundation based in the Netherlands, as well as a Principal Investigator at the Academic Medical Center (AMC), University of Amsterdam. He specializes in HIV/AIDS with a focus on affordable diagnostics, HIV epidemiology and HIV drug resistance.